Skip to main content
H. Lundbeck A logo

H. Lundbeck A — Investor Relations & Filings

Ticker · HLUN ISIN · DK0061804770 LEI · 5493006R4KC2OI5D3470 CO Manufacturing
Filings indexed 947 across all filing types
Latest filing 2025-08-13 Earnings Release
Country DK Denmark
Listing CO HLUN

About H. Lundbeck A

https://www.lundbeck.com/global

H. Lundbeck A/S is a global biopharmaceutical company specializing in brain diseases. The company is engaged in the research, development, manufacturing, and marketing of transformative therapies for a range of psychiatric and neurological disorders. Its portfolio and pipeline focus on conditions such as depression, mood disorders, and rare childhood-onset epilepsies. Lundbeck is dedicated to advancing neuroscience to improve the quality of life for individuals affected by central nervous system disorders.

Recent filings

Filing Released Lang Actions
Earnings Release 2025
Earnings Release Classification · 100% confidence The document is a corporate release announcing an update to the company's financial guidance for 2025. It provides key highlights of revenue and EBITDA growth expectations, which is characteristic of an Earnings Release (ER). While it mentions that a full financial report will be released shortly, the document itself serves as the primary announcement of the revised financial outlook, fitting the definition of an Earnings Release rather than a report publication announcement. H1 2025
2025-08-13 English
Earnings Release 2025
Earnings Release Classification · 100% confidence The document is a 'Corporate Release' from H. Lundbeck A/S announcing an upward revision of their 2025 financial guidance. It provides key highlights of revenue and EBITDA growth expectations, which is characteristic of an Earnings Release (ER). While it mentions that a full financial report will be released shortly, the document itself contains the primary financial news and updated guidance, distinguishing it from a mere report publication announcement (RPA). H1 2025
2025-08-13 English
Director's Dealing 2025
Director's Dealing Classification · 100% confidence The document is titled "Transactions with shares and linked securities in Lundbeck made by executives and their closely associated parties" and explicitly details a 'Purchase of shares' transaction by a 'Member of the board of directors' (Ilse Dorothea Wenzel) on a specific date (2025-02-21). This content directly corresponds to the reporting of personal share transactions by company directors and executives, which is the definition of Director's Dealing.
2025-02-21 English
Director's Dealing 2025
Director's Dealing Classification · 100% confidence The document explicitly details 'Transactions with shares and linked securities in Lundbeck made by executives and their closely associated parties.' It lists a specific transaction (Purchase of shares) by a 'Member of the board of directors' (Ilse Dorothea Wenzel). This content directly corresponds to the definition of Director's Dealing (insider trades by executives/directors). The filing type code for this is DIRS.
2025-02-21 English
Director's Dealing 2025
Director's Dealing Classification · 100% confidence The document is titled "Transactions with shares and linked securities in Lundbeck made by executives and their closely associated parties" and details specific share transactions (vesting of Restricted Shares) by individuals holding managerial responsibilities (CFO, EVP, etc.). This type of filing, reporting personal share transactions by company directors and executives, directly corresponds to the definition of Director's Dealing. Filing Definition 9: Director's Dealing (Code: DIRS) - Report of personal share transactions by company directors and executives (insider trades).
2025-02-05 English
Director's Dealing 2025
Director's Dealing Classification · 100% confidence The document explicitly details 'Transactions with shares and linked securities in Lundbeck made by executives and their closely associated parties'. It lists specific individuals (executives/CFO), the nature of the transaction ('vesting of Restricted Shares'), and the date. This content directly corresponds to insider trading reports or disclosures regarding personal share transactions by directors and executives, which maps precisely to the 'Director's Dealing' category (DIRS). It is not a general earnings release (ER), a full annual report (10-K), or a proxy statement (DEF 14A/PSI).
2025-02-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.